Cardiometabolic characterization in metabolic dysfunction–associated fatty liver disease

BACKGROUND: To better understand the patient's heterogeneity in fatty liver disease (FLD), metabolic dysfunction–associated fatty liver disease (MAFLD) was proposed by international experts as a new nomenclature for nonalcoholic fatty liver disease (NAFLD). We aimed to evaluate the cardiovascul...

Descripción completa

Detalles Bibliográficos
Autores principales: Perdomo, Carolina M., Núñez-Córdoba, Jorge M., Ezponda, Ana, Mendoza, Francisco J., Ampuero, Javier, Bastarrika, Gorka, Frühbeck, Gema, Escalada, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632176/
https://www.ncbi.nlm.nih.gov/pubmed/36341262
http://dx.doi.org/10.3389/fmed.2022.1023583

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9632176/
https://www.ncbi.nlm.nih.gov/pubmed/36341262
http://dx.doi.org/10.3389/fmed.2022.1023583

Ejemplares similares